Patents by Inventor Laura J. Duggan

Laura J. Duggan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8293188
    Abstract: In some embodiments, the present invention pertains to a method for detecting an adulterant in a biological sample. A combination of a biological sample, an agent for detecting the adulterant and an ionic moiety capable of undergoing reduction by gaining electrons is provided in an assay medium. The combination is incubated under conditions sufficient for the ionic moiety to undergo reduction and for the agent for detecting the adulterant to interact with the adulterant. The reduction of the ionic moiety enhances the detection of the adulterant as a result of increasing the sensitivity of the agent for detecting the adulterant. The extent of interaction between the agent for detecting the adulterant and the adulterant is measured and is related to the presence or absence of the adulterant in the biological sample.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: October 23, 2012
    Assignee: Siemens Healthcare Diagnostics, Inc.
    Inventors: Yuri Bukhtiyarov, Cathey M Briggs, Laura J Duggan
  • Publication number: 20100150778
    Abstract: In some embodiments, the present invention pertains to a method for detecting an adulterant in a biological sample. A combination of a biological sample, an agent for detecting the adulterant and an ionic moiety capable of undergoing reduction by gaining electrons is provided in an assay medium. The combination is incubated under conditions sufficient for the ionic moiety to undergo reduction and for the agent for detecting the adulterant to interact with the adulterant. The reduction of the ionic moiety enhances the detection of the adulterant as a result of increasing the sensitivity of the agent for detecting the adulterant. The extent of interaction between the agent for detecting the adulterant and the adulterant is measured and is related to the presence or absence of the adulterant in the biological sample.
    Type: Application
    Filed: February 24, 2010
    Publication date: June 17, 2010
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Yuri Bukhtiyarov, Cathey M. Briggs, Laura J. Duggan
  • Patent number: 7695975
    Abstract: In some embodiments, the present invention pertains to a method for detecting an adulterant in a biological sample. A combination of a biological sample, an agent for detecting the adulterant and an ionic moiety capable of undergoing reduction by gaining electrons is provided in an assay medium. The combination is incubated under conditions sufficient for the ionic moiety to undergo reduction and for the agent for detecting the adulterant to interact with the adulterant. The reduction of the ionic moiety enhances the detection of the adulterant as a result of increasing the sensitivity of the agent for detecting the adulterant. The extent of interaction between the agent for detecting the adulterant and the adulterant is measured and is related to the presence or absence of the adulterant in the biological sample.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: April 13, 2010
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Yuri Bukhtiyarov, Cathey M. Briggs, Laura J. Duggan